-
1
-
-
79953703529
-
Trends in the use and expenditures for COX-2 inhibitors and traditional nonsteroideal anti-inflammatory drugs, 1997-2003
-
Agency for Healthcare Research and Quality
-
Banthin JS, Zodet M. Trends in the use and expenditures for COX-2 inhibitors and traditional nonsteroideal anti-inflammatory drugs, 1997-2003. Statistical Brief #139. Agency for Healthcare Research and Quality. URL: http://www.meps.ahrq.gov/mepsweb/data-files/publications/st139/stat139.shtml.
-
Statistical Brief
, Issue.139
-
-
Banthin, J.S.1
Zodet, M.2
-
2
-
-
78650633681
-
Inhibition of matrix metalloproteinase-3 and -13 synthesis induced by IL-1β in chondrocytes from mice lacking microsomal prostaglandin e synthase-1
-
Gosset M, Pigenet A, Salvat C, Berenbaum F, Jacques C. Inhibition of matrix metalloproteinase-3 and -13 synthesis induced by IL-1β in chondrocytes from mice lacking microsomal prostaglandin E synthase-1. J Immunol 2010;185:6244-52.
-
(2010)
J Immunol
, vol.185
, pp. 6244-6252
-
-
Gosset, M.1
Pigenet, A.2
Salvat, C.3
Berenbaum, F.4
Jacques, C.5
-
3
-
-
0034455647
-
The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: An analysis using specific agonists for the respective EPs
-
DOI 10.1210/en.141.4.1554
-
Suzawa T, Miyaura C, Inada M, Maruyama T, Sugimoto Y, Ushikubi F, et al. The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs. Endocrinology 2000;141: 1554-9. (Pubitemid 32269125)
-
(2000)
Endocrinology
, vol.141
, Issue.4
, pp. 1554-1559
-
-
Suzawa, T.1
Miyaura, C.2
Inada, M.3
Maruyama, T.4
Sugimoto, Y.5
Ushikubi, F.6
Ichikawa, A.7
Narumiya, S.8
Suda, T.9
-
4
-
-
75749128263
-
2 modulate the synthesis of osteoprotegerin and RANKL in the cartilage of patients with severe knee osteoarthritis
-
Moreno-Rubio J, Herrero-Beaumont G, Tardio L, Alvarez-Soria MA, Largo R. Nonsteroidal antiinflammatory drugs and prostaglandin E2 modulate the synthesis of osteoprotegerin and RANKL in the cartilage of patients with severe knee osteoarthritis. Arthritis Rheum 2010;62:478-88.
-
(2010)
Arthritis Rheum
, vol.62
, pp. 478-488
-
-
Moreno-Rubio, J.1
Herrero-Beaumont, G.2
Tardio, L.3
Alvarez-Soria, M.A.4
Largo, R.5
-
5
-
-
57349169432
-
2 exerts catabolic effects in osteoarthritis cartilage: Evidence for signaling via the EP4 receptor
-
Attur M, Al-Mussawir HE, Patel J, Kitay A, Dave M, Palmer G, et al. Prostaglandin E2 exerts catabolic effects in osteoarthritis cartilage: evidence for signaling via the EP4 receptor. J Immunol 2008;181:5082-8.
-
(2008)
J Immunol
, vol.181
, pp. 5082-5088
-
-
Attur, M.1
Al-Mussawir, H.E.2
Patel, J.3
Kitay, A.4
Dave, M.5
Palmer, G.6
-
6
-
-
70350523833
-
2 dependent proliferation of growth plate chondrocytes
-
Brochhausen C, Neuland P, Kirkpatrick CJ, Nusing RM, Klaus G. Cyclooxygenases and prostaglandin E2 receptors in growth plate chondrocytes in vitro and in situ: prostaglandin E2 dependent proliferation of growth plate chondrocytes. Arthritis Res Ther 2006;8:R78.
-
(2006)
Arthritis Res Ther
, vol.8
-
-
Brochhausen, C.1
Neuland, P.2
Kirkpatrick, C.J.3
Nusing, R.M.4
Klaus, G.5
-
7
-
-
0041384418
-
2 in chondrocyte differentiation
-
DOI 10.1016/S1063-4584(03)00118-3
-
Miyamoto M, Ito H, Mukai S, Kobayashi T, Yamamoto H, Kobayashi M, et al. Simultaneous stimulation of EP2 and EP4 is essential to the effect of prostaglandin E2 in chondrocyte differentiation. Osteoarthritis Cartilage 2003;11:644-52. (Pubitemid 37045683)
-
(2003)
Osteoarthritis and Cartilage
, vol.11
, Issue.9
, pp. 644-652
-
-
Miyamoto, M.1
Ito, H.2
Mukai, S.3
Kobayashi, T.4
Yamamoto, H.5
Kobayashi, M.6
Maruyama, T.7
Akiyama, H.8
Nakamura, T.9
-
8
-
-
67649616236
-
Prostaglandin EP2 and EP4 receptor agonists in bone formation and bone healing: In vivo and in vitro evidence
-
Graham S, Gamie Z, Polyzois I, Narvani AA, Tzafetta K, Tsiridis E, et al. Prostaglandin EP2 and EP4 receptor agonists in bone formation and bone healing: in vivo and in vitro evidence. Expert Opin Investig Drugs 2009;18:746-66.
-
(2009)
Expert Opin Investig Drugs
, vol.18
, pp. 746-66
-
-
Graham, S.1
Gamie, Z.2
Polyzois, I.3
Narvani, A.A.4
Tzafetta, K.5
Tsiridis, E.6
-
10
-
-
59649098933
-
2 and its cognate EP receptors control human adult articular cartilage homeostasis and are linked to the pathophysiology of osteoarthritis
-
Li X, Ellman M, Muddasani P, Wang JH, Cs-Szabo G, van Wijnen AJ, et al. Prostaglandin E2 and its cognate EP receptors control human adult articular cartilage homeostasis and are linked to the pathophysiology of osteoarthritis. Arthritis Rheum 2009;60: 513-23.
-
(2009)
Arthritis Rheum
, vol.60
, pp. 513-523
-
-
Li, X.1
Ellman, M.2
Muddasani, P.3
Wang, J.H.4
Cs-Szabo, G.5
Van Wijnen, A.J.6
-
11
-
-
34648814090
-
2 at very low concentrations suppresses collagen cleavage in cultured human osteoarthritic articular cartilage: This involves a decrease in expression of proinflammatory genes, collagenases and COL10A1, a gene linked to chondrocyte hypertrophy
-
DOI 10.1186/ar2273
-
Tchetina EV, Di Battista JA, Zukor DJ, Antoniou J, Poole AR. Prostaglandin PGE2 at very low concentrations suppresses collagen cleavage in cultured human osteoarthritic articular cartilage: this involves a decrease in expression of proinflammatory genes, collagenases and COL10A1, a gene linked to chondrocyte hypertrophy. Arthritis Res Ther 2007;9:R75. (Pubitemid 47455044)
-
(2007)
Arthritis Research and Therapy
, vol.9
, Issue.4
-
-
Tchetina, E.V.1
Di Battista, J.A.2
Zukor, D.J.3
Antoniou, J.4
Poole, A.R.5
-
12
-
-
66249134556
-
2 inhibits BMP signaling and delays chondrocyte maturation
-
Clark CA, Li TF, Kim KO, Drissi H, Zuscik MJ, Zhang X, et al. Prostaglandin E2 inhibits BMP signaling and delays chondrocyte maturation. J Orthop Res 2009;27:785-92.
-
(2009)
J Orthop Res
, vol.27
, pp. 785-792
-
-
Clark, C.A.1
Li, T.F.2
Kim, K.O.3
Drissi, H.4
Zuscik, M.J.5
Zhang, X.6
-
13
-
-
37149052447
-
Hypoxia-inducible factor 1α is involved in the prostaglandin metabolism of osteoarthritic cartilage through up-regulation of microsomal prostaglandin E synthase 1 in articular chondrocytes
-
DOI 10.1002/art.23136
-
Grimmer C, Pfander D, Swoboda B, Aigner T, Mueller L, Hennig FF, et al. Hypoxia-inducible factor 1α is involved in the prostaglandin metabolism of osteoarthritic cartilage through up-regulation of microsomal prostaglandin E synthase 1 in articular chondrocytes. Arthritis Rheum 2007;56:4084-94. (Pubitemid 350262336)
-
(2007)
Arthritis and Rheumatism
, vol.56
, Issue.12
, pp. 4084-4094
-
-
Grimmer, C.1
Pfander, D.2
Swoboda, B.3
Aigner, T.4
Mueller, L.5
Hennig, F.F.6
Gelse, K.7
-
14
-
-
0036259278
-
Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair
-
DOI 10.1172/JCI200215681
-
Zhang X, Schwarz EM, Young DA, Puzas JE, Rosier RN, O'Keefe RJ. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 2002;109:1405-15. (Pubitemid 34596166)
-
(2002)
Journal of Clinical Investigation
, vol.109
, Issue.11
, pp. 1405-1415
-
-
Zhang, X.1
Schwarz, E.M.2
Young, D.A.3
Edward Puzas, J.4
Rosier, R.N.5
O'Keefe, R.J.6
-
15
-
-
67349120238
-
Sox9 directly promotes Bapx1 gene expression to repress Runx2 in chondrocytes
-
Yamashita S, Andoh M, Ueno-Kudoh H, Sato T, Miyaki S, Asahara H. Sox9 directly promotes Bapx1 gene expression to repress Runx2 in chondrocytes. Exp Cell Res 2009;315:2231-40.
-
(2009)
Exp Cell Res
, vol.315
, pp. 2231-40
-
-
Yamashita, S.1
Andoh, M.2
Ueno-Kudoh, H.3
Sato, T.4
Miyaki, S.5
Asahara, H.6
-
16
-
-
79953692404
-
2 receptor-specific agonist in combination with a low dose of growth factor heals critical-size bone defects in mice
-
Kamolratanakul P, Hayata T, Ezura Y, Kawamata A, Hayashi C, Yamamoto Y, et al. Nanogel-based scaffold delivery of prostaglandin E2 receptor-specific agonist in combination with a low dose of growth factor heals critical-size bone defects in mice. Arthritis Rheum 2011;63:1021-33.
-
(2011)
Arthritis Rheum
, vol.63
, pp. 1021-33
-
-
Kamolratanakul, P.1
Hayata, T.2
Ezura, Y.3
Kawamata, A.4
Hayashi, C.5
Yamamoto, Y.6
|